Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
923 trades
$2B in total
Open-market sales
1,038 trades
$2.3B in total
Insiders filing
464 insiders
Last 7 days
Trade type
CEO and President
PharmaCyte BiotechPMCB
Open-market buy01/05–01/0701/07100,000 sh3 trades$0.80avg.$80,300+31.6%
Director
PharmaCyte BiotechPMCB
Open-market buy01/05–01/0701/0760,000 sh3 trades$0.80avg.$48,200+45.3%